Trial Profile
Olmesartan Mega study to determine the relationship between Cardiovascular Endpoints and Blood pressure Goal Achievement
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Nov 2016
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary)
- Indications Essential hypertension
- Focus Adverse reactions; Therapeutic Use
- Sponsors Daiichi Sankyo Company
- 16 Jun 2016 New trial record